Solutions & Services
Therapeutic expertise
Why APICES
Hematology studies are shaped by constraint rather than scale. Patient populations are limited, eligibility criteria are often tightly defined, and treatment is concentrated in a small number of specialist centers. Recruitment does not hinge on how many sites are opened, but on whether the right clinicians are engaged at the right moment in the care pathway.
APICES brings hematology expertise based on executing studies in these conditions. We understand how prior therapies, complex treatment sequences, and safety considerations influence both feasibility and site participation. This insight feeds directly into study design, helping ensure that assumptions around enrollment, visit schedules, and monitoring intensity reflect how hematology care is delivered in practice.
%
In hematology, execution risk is introduced early. Design decisions around eligibility, visit burden, and monitoring intensity can determine whether specialist sites commit or decline. APICES works at this stage, helping shape studies so they fit within the operational and clinical reality of expert centers.
The result is a study setup that specialist sites can support, recruitment assumptions that remain credible once the study starts, and an execution model that does not rely on corrective measures later.
Talk to our team about how execution realities may shape the feasibility and timelines of your hematology study.
When moving from protocol to first European execution →
When scale, consistency, and delivery discipline matter →